The Association of Small Dense Low-Density Lipoprotein Cholesterol and Coronary Heart Disease in Subjects at High Cardiovascular Risk-Reference-Cited by-同舟云学术

The Association of Small Dense Low-Density Lipoprotein Cholesterol and Coronary Heart Disease in Subjects at High Cardiovascular Risk

Published:2021-01-01 Issue:1 Volume:28 Page:79-89
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:JAT

Author:

Higashioka Mayu¹²,Sakata Satoko¹³⁴,Honda Takanori¹,Hata Jun¹³⁴,Shibata Mao¹³,Yoshida Daigo¹,Goto Kenichi⁴,Kitazono Takanari³⁴,Osawa Haruhiko²,Ninomiya Toshiharu¹³

Affiliation:

1. Department of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University

2. Department of Diabetes and Molecular Genetics, Graduate School of Medicine

3. Center for Cohort Studies, Graduate School of Medical Sciences, Kyushu University

4. Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University

Publisher

Japan Atherosclerosis Society

Subject

Biochemistry (medical),Cardiology and Cardiovascular Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/jat/28/1/28_55350/_pdf

Reference20 articles.

1. 1) Collaborators GBDCoD: Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet, 2018; 392: 1736-1788

2. 2) Vital Health and Social Statistics Office, Ministry of Health, Labour and Welfare: Vital Statistics. Available from:https://www.e-stat.go.jp/dbview?sid=0003214721, Accessed 2020 Jan 17

3. 3) Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R; Cholesterol Treatment Trialists' (CTT) Collaborators: Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet, 2005; 366: 1267-1278

4. 4) Kinoshita M, Yokote K, Arai H, Iida M, Ishigaki Y, Ishibashi S, Umemoto S, Egusa G, Ohmura H, Okamura T, Kihara S, Koba S, Saito I, Shoji T, Daida H, Tsukamoto K, Deguchi J, Dohi S, Dobashi K, Hamaguchi H, Hara M, Hiro T, Biro S, Fujioka Y, Maruyama C, Miyamoto Y, Murakami Y, Yokode M, Yoshida H, Rakugi H, Wakatsuki A, Yamashita S; Committee for Epidemiology and Clinical Management of Atherosclerosis: Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017. J Atheroscler Thromb, 2018; 25: 846-984

5. 5) Nishimura K, Okamura T, Watanabe M, Nakai M, Takegami M, Higashiyama A, Kokubo Y, Okayama A, Miyamoto Y: Predicting coronary heart disease using risk factor categories for a Japanese urban population, and comparison with the framingham risk score: the suita study. J Atheroscler Thromb, 2014; 21: 784-798

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low-density lipoprotein cholesterol and risk of hepatocellular carcinoma: a Mendelian randomization and mediation analysis;Lipids in Health and Disease;2023-07-31

2. Small Dense LDL Level and LDL/HDL Distribution in Acute Coronary Syndrome Patients;Biomedicines;2023-04-18

3. Small dense low-density lipoprotein cholesterol compared to other lipoprotein biomarkers for predicting coronary heart disease among individuals with normal fasting glucose: The Multi-Ethnic Study of Atherosclerosis;American Journal of Preventive Cardiology;2023-03

4. Role of Small Dense Low-density Lipoprotein Cholesterol in Cardiovascular Events in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus Receiving Statin Treatment;Journal of Atherosclerosis and Thrombosis;2023

5. Calculated Small Dense Low-Density Lipoprotein Cholesterol Level is A Predominant Predictor for New Onset of Ischemic Heart Disease;Journal of Atherosclerosis and Thrombosis;2023